Published June 1, 2023 Christopher Newman Editor An injector and box of Yusimry, an autoimmune disease drug developed by Coherus BioSciences and approved in the U.S. in December 2021. Courtesy of Coherus BioSciences Dive Brief: Coherus BioSciences plans to launch its copycat version of AbbVie’s autoimmune disease drug Humira next month at an 85% discount to...
